Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

Melanoma Drug Zelboraf Gives Cancer Survivor Second Chance at Life

POSTED: February 24, 2012 Share

In this "4 Your Health" KNBC Los Angeles news profile, cancer survivor Louise Belley, 60, shares her story of battling metastatic melanoma and the benefits of the drug treatment Zelboraf, tested in clinical trials by Jonsson Comprehensive Cancer Center researcher Antoni Ribas and scientists from 12 other sites in the United States and Australia.


Last updated: 3/15/2012 11:37:30 AM